Lassa fever historical perspective

Jump to navigation Jump to search

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever historical perspective

CDC on Lassa fever historical perspective

Lassa fever historical perspective in the news

Blogs on Lassa fever historical perspective

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Historic Perspective

  • Lassa fever is an acute viral illness that occurs in west Africa. The illness was discovered in 1969 when two missionary nurses died in Nigeria. The virus is named after the town in Nigeria where the first cases occurred. The virus, a member of the virus family Arenaviridae, is a single-stranded RNA virus and is zoonotic, or animal-borne.
  • The illness was discovered in 1969 when two missionary nurses died in Nigeria, West Africa. The cause of the illness was found to be Lassa virus, named after the town in Nigeria where the first cases originated. Early and aggressive treatment using Ribavirin was pioneered by Joe McCormick in 1979.
  • Lassa fever is endemic in parts of west Africa including Sierra Leone, Liberia, Guinea and Nigeria; however, other neighboring countries are also at risk, as the animal vector for Lassa virus, the "multimammate rat" (Mastomys natalensis) is distributed throughout the region. In 2009, the first case from Mali was reported in a traveler living in southern Mali; Ghana reported its first cases in late 2011. Isolated cases have also been reported in Côte d’Ivoire and Burkina Faso and there is serologic evidence of Lassa virus infection in Togo and Benin.
  • The number of Lassa virus infections per year in west Africa is estimated at 100,000 to 300,000, with approximately 5,000 deaths. Unfortunately, such estimates are crude, because surveillance for cases of the disease is not uniformly performed. In some areas of Sierra Leone and Liberia, it is known that 10%-16% of people admitted to hospitals every year have Lassa fever, which indicates the serious impact of the disease on the population of this region. [1]
  • Based on the sero-epidemiological studies, it is estimated that Lassa fever might have occurred without clinical recognition years before the first case reported in 1969. Few such cases are mentioned below.
  • 14 day history of fever, rash, headache, bradycardia, puffy face was reported on a Nigerian Missionary from Makurdi in 1935.
  • Lassa neutralizing antibody was obtained from a patient who was a missionary in Nigeria by Henderson et al. in 1971 and he had a history of Lassa like illness in 1952.
  • In Eastern Province and Sierra Leone, epidemics which has clinical and epidemiological resemblance to Lassa fever has been reported in 1955-1956.

References

  1. "The Centers for Disease Control and Prevention".


Template:WikiDoc Sources